0920-AA63 201610 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0920 Centers for Disease Control and Prevention CDC 0900 Department of Health and Human Services HHS Control of Communicable Diseases

This rule clarifies data collection requirements for airline passengers and crew, codifies current practice, clarifies HHS/CDC's authority to implement non-invasive public health screenings at U.S. ports of entry and other U.S. locations; and adds appeal provisions for persons served with a Federal public health order (e.g., quarantine) with due process, including clarification of reasons, processes, and reassessments.

]]> Other Significant Previously Published in The Unified Agenda Final Rule Stage Yes No 42 CFR 70 42 CFR 71 sec. 361 of the Public Health Service Act (42 U.S.C. 264 to 265) Yes

The need for this proposed rulemaking was reinforced during HHS/CDC’s response to the largest outbreak of Ebola virus disease (Ebola) on record, followed by the recent outbreak of Middle East Respiratory Syndrome (MERS) in South Korea, both quarantinable communicable diseases, and repeated outbreaks and responses to measles, a non-quarantinable communicable disease of public health concern, in the United States. The provisions contained within this proposal will enhance HHS/CDC’s ability to prevent the further importation and spread of communicable diseases into the United States and interstate by clarifying and providing greater transparency regarding its response capabilities and practices. 

]]>

The primary legal authority supporting this rulemaking is sections 361 and 362 of the Public Health Service Act (42 U.S.C. 264, 265).

]]>

None.  The main impact of the proposals within this rule is to strengthen our regulations by codifying statutory language to describe HHS/CDC’s authority to prevent the introduction, transmission, and spread of communicable diseases. The intent of these proposed updates is to best protect U.S. public health and to inform the regulated community of these updates.

 

]]>

The analysis of estimated costs and benefits of this rule has 4 components: 1) costs and benefits for submitting passenger and crew information to CDC; 2) costs and benefits associated with improved transparency of how HHS/CDC uses its regulatory authorities to protect public health; 3) transfer payments by HHS/CDC for treatment and care; and 4) the impact of the proposed provision suspending the entry of animals, articles, or things from designated foreign countries and places into the United States.  

]]>

If this regulation is not published, HHS/CDC’s ability to prevent the further importation and spread of communicable diseases into the United States and interstate will be limited; current regulatory language will not be clarified; and there will be less transparency to the public regarding HHS/CDC’s response capabilities and practices.

]]> NPRM 08/15/2016 81 FR 54230 NPRM Comment Period End 10/14/2016 Final Rule 12/00/2016 No No Federal No No No Yes Ashley Marrone Public Health Analyst 0920 Centers for Disease Control and Prevention CDC 404 498-1600 amarrone@cdc.gov 1600 Clifton Road NE., MS-E03, Atlanta GA 30329